Ann Thor
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 3
-
- Cell death mechanisms and regulation 2
- Ubiquitin and proteasome pathways 1
- S100 Proteins and Annexins 1
- Co-authors
- Britt‐Marie Ljung (3 shared papers)Helene S. Smith (3 shared papers)Christopher C. Benz (1 shared paper)Maurice Barcos (1 shared paper)Mei He (1 shared paper)Marc A. Shuman (2 shared papers)Elisabetta Bianchi (2 shared papers)Randall D. Gaz (1 shared paper)
- Journals
- International Journal of Oncology (1 paper)International Journal of Cancer (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Oncology Reports (1 paper)PubMed (5 papers)
- Partner nations
- United StatesItaly
In The Last Decade
Ann Thor
9 papers receiving 731 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 296
- Oncology 369
- Immunology and Allergy 74
- Endocrinology, Diabetes and Metabolism 124
- Hematology 75
Countries citing papers authored by Ann Thor
This map shows the geographic impact of Ann Thor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Thor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Thor more than expected).
Fields of papers citing papers by Ann Thor
This network shows the impact of papers produced by Ann Thor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Thor. The network helps show where Ann Thor may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Thor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. | 1992 | 161 |
| 2 | 1991 | 139 | |
| 3 | The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. | 1994 | 139 |
| 4 | Loss of heterozygosity and p53 gene mutations in breast cancer. | 1994 | 104 |
| 5 | ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. | 1986 | 89 |
| 6 | 1995 | 56 | |
| 7 | 2005 | 33 | |
| 8 | 2007 | 18 | |
| 9 | ras oncogene p21 expression in hepatocellular carcinoma. | 1989 | 12 |
About Ann Thor
Ann Thor is a scholar working on Oncology, Molecular Biology, Cancer Research, Pathology and Forensic Medicine and Immunology and Allergy, having authored 9 papers that have together received 751 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers), Cell Adhesion Molecules Research (2 papers), Genetic factors in colorectal cancer (2 papers), Ubiquitin and proteasome pathways (1 paper), Cancer Genomics and Diagnostics (1 paper), S100 Proteins and Annexins (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Cancer Research (296 citations), Oncology (369 citations), Immunology and Allergy (74 citations), Endocrinology, Diabetes and Metabolism (124 citations) and Hematology (75 citations). Ann Thor has collaborated with scholars based in United States and Italy. Frequent co-authors include Britt‐Marie Ljung, Helene S. Smith, Christopher C. Benz, Maurice Barcos, Mei He, Marc A. Shuman, Elisabetta Bianchi, Randall D. Gaz, Jenn‐Kuen Lee and J. Larry Jameson. Their work appears in journals such as International Journal of Oncology, International Journal of Cancer, The Journal of Clinical Endocrinology & Metabolism, Oncology Reports and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.